Suppr超能文献

先前未描述的大片段缺失导致常染色体隐性痉挛性截瘫。

Previously Undescribed Gross Deletions as a Cause of Autosomal Recessive Spastic Paraplegia.

机构信息

Research Centre for Medical Genetics, 115522 Moscow, Russia.

出版信息

Genes (Basel). 2022 Nov 23;13(12):2186. doi: 10.3390/genes13122186.

Abstract

Spastic paraplegia and psychomotor retardation with or without seizures (SPPRS, OMIM 616756) is a rare genetic disease caused by biallelic pathogenic variants in the gene. Originally, these mutations have been reported to be implicated in tumor predisposition. Nonetheless, via whole exome sequencing in 2015, mutations were suggested to be the cause of a new autosomal recessive neurodevelopmental disorder, which is characterized by spasticity, muscular hypotonia, and intellectual disability. To date, 14 pathogenic variants have been described; these variants have a loss-of-function effect that leads to clinical presentations with variable severities. However, gross deletions in the gene have not yet been mentioned as a cause of spastic paraplegia. Here, we report a clinical case involving a 2-year-old male presenting with spasticity, mainly affecting the lower limbs, and developmental delay. Exome sequencing, chromosomal microarray analysis, and mRNA analysis were used to identify the causative gene. We revealed that the clinical findings were due to previously undescribed biallelic deletions. We identified the deletion of exon 7: c.(534+1_535-1)_(617+1_618-1)del (NM_020771.4) and the gross deletion in the 6q16.3 locus, which affected the entire gene: g.105018931_105337494del, (GRCh37). A comprehensive diagnostic approach for the patients with originally homozygous mutations in is required since false homozygosity results are possible. More than 80% of the described mutations were reported to be homozygous. Initial hemizygosity is hard to detect by quantitative methods, and this may challenge molecular diagnostic identification in patients with spastic paraplegia.

摘要

痉挛性截瘫伴精神运动迟缓或不伴癫痫(SPPRS,OMIM 616756)是一种罕见的遗传性疾病,由 基因中的双等位致病性变异引起。最初,这些突变已被报道与肿瘤易感性有关。然而,通过 2015 年的全外显子组测序,发现 突变是一种新的常染色体隐性神经发育障碍的原因,其特征是痉挛、肌肉张力减退和智力障碍。迄今为止,已有 14 种致病性变异被描述;这些变异具有功能丧失效应,导致临床表现具有不同的严重程度。然而, 基因的大片段缺失尚未被提及为痉挛性截瘫的原因。在这里,我们报告了一个临床病例,涉及一名 2 岁男性,表现为痉挛,主要影响下肢,以及发育迟缓。外显子组测序、染色体微阵列分析和 mRNA 分析用于鉴定致病基因。我们发现临床发现是由于以前未描述的 基因的双等位缺失引起的。我们鉴定了外显子 7 的缺失:c.(534+1_535-1)_(617+1_618-1)del(NM_020771.4)和 6q16.3 位点的大片段缺失,影响整个 基因:g.105018931_105337494del,(GRCh37)。对于最初在 基因中具有纯合突变的患者,需要进行全面的诊断方法,因为可能存在假纯合性结果。超过 80%的描述突变被报告为纯合子。定量方法很难检测到最初的半合子,这可能会挑战痉挛性截瘫患者的分子诊断识别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f747/9778407/fed74532d945/genes-13-02186-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验